Progressive Care Inc. Announces Steady Sales Growth in May
June 25 2019 - 11:08AM
InvestorsHub NewsWire
Progressive Care Inc. Announces Steady Sales Growth in May
MIAMI, FL -- June 25, 2019 -- InvestorsHub NewsWire
-- Progressive Care Inc. (OTCQB: RXMD), a
personalized healthcare services and technology company, today
announced further growth year-over-year in revenue and number of
prescriptions filled for May 2019 and a record month for PharmCo
revenue in Palm Beach, which increased at 98%.
May 2019 sales have remained solid after April’s record-breaking
month. The Company filled nearly 28,500 prescriptions between the 2
locations, an increase of 13% over the same month last year.
Progressive Care recorded over $1.8 million in net revenues
exclusive of PBM fees.
“The Company is recording year-over-year growth despite drastic
reimbursement contraction and aggressive PBM fees,” said S. Parikh
Mars, Chief Executive Officer of Progressive Care Inc. “We are
confident that our efforts to build momentum and market penetration
is producing the desired results. We expect to leverage our
capabilities and the positive growth trajectory to accelerate our
progress once the 2 new locations are properly integrated.”
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its
PharmCo, LLC, is a South Florida health services organization and
provider of prescription pharmaceuticals, compounded medications,
provider of tele-pharmacy services, the sale of anti-retroviral
medications, medication therapy management (MTM), the supply of
prescription medications to long-term care facilities, and health
practice risk management.
Cautionary Statement Regarding Forward-Looking
Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words “anticipate,” “believe,” “estimate,” “upcoming,”
“plan,” “target,” “intend” and “expect” and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject to a
number of risks, uncertainties, and other factors that could cause
the Company’s actual results, performance, prospects, and
opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Kathleen Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024